$2.060
-0.086 (-4.19%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACRV por análisis de gráficos similares
Alphio's ACRV stock price prediction model matches the current Acrivon Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.09 (+1.34%). The 1-week path is $1.89 (-8.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Acrivon Therapeutics, Inc.?
Acrivon Therapeutics Inc is a good buy right now due to its potential upside indicated by an analyst price target of $8, which represents a significant upside from the current price of $2.06. Additionally, the stock has shown a strong 1-year change of +53.73%, suggesting positive momentum over the longer term. The main risk is the ongoing losses, with a net income of -$19,064,000 reported for Q2 2026, which highlights profitability challenges that investors should monitor closely.
ACRV cerró en $2.06 el Friday, tras bajar -4.19%
Acrivon Therapeutics, Inc. (ACRV) last closed at $2.06, losing -4.19%. These facts feed the 1-day and 1-week ACRV price prediction above.
Factores de la previsión
Los factores de la previsión de Acrivon Therapeutics, Inc. (ACRV) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACRV, ordenadas por similitud.
Análisis de estacionalidad de ACRV
Historically the probability of a positive August return for ACRV is 34.92%. November offers the highest probability of a positive month at 51.28%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACRV
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.98 | $1.20 | $1.26 | -41.51% |
| Sep 2026 | $1.31 | $1.33 | $1.55 | -35.20% |
| Oct 2026 | $1.11 | $1.37 | $1.58 | -33.66% |
| Nov 2026 | $1.48 | $1.55 | $1.73 | -24.87% |
| Dec 2026 | $1.21 | $1.27 | $1.53 | -38.50% |
En 2026, se proyecta que Acrivon Therapeutics, Inc. (ACRV) oscile entre $0.98 y $1.73.
Previsión mensual de Acrivon Therapeutics, Inc. para 2026
En Aug de 2026, se proyecta que Acrivon Therapeutics, Inc. promedie $1.20, con un mínimo de $0.98 y un máximo de $1.26.
En Sep de 2026, se proyecta que Acrivon Therapeutics, Inc. promedie $1.33, con un mínimo de $1.31 y un máximo de $1.55.
En Oct de 2026, se proyecta que Acrivon Therapeutics, Inc. promedie $1.37, con un mínimo de $1.11 y un máximo de $1.58.
En Nov de 2026, se proyecta que Acrivon Therapeutics, Inc. promedie $1.55, con un mínimo de $1.48 y un máximo de $1.73.
En Dec de 2026, se proyecta que Acrivon Therapeutics, Inc. promedie $1.27, con un mínimo de $1.21 y un máximo de $1.53.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.